Curcumin-β-D-glucuronide, a principal metabolite detected in hepatic tissue and portal blood following oral consumption of Curcumin, is utilized in colon cancer research [1] [2].

姜黄素-β-D-葡萄糖醛酸苷（每公斤90毫克，每周三次，腹腔注射，连续3周）对KRAS突变/TP53野生型HCT116异种移植模型具有显著的抗肿瘤效果[1]。